Inhibition of CD28 expression by oligonucleotide decoys to the regulatory element in exon 1 of the CD28 gene

Journal of Immunology

Volumn 163, Issue 8, 1999, Pages 4292-4299

  Tam, Robert C ^a   Lin, Catherine J ^a   Lim, Charmaine ^a   Pai, Bharati ^a   Stoisavljevic, Vesna ^a  

^a Valeant Pharmaceuticals International   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; GUANOSINE; OLIGONUCLEOTIDE; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR SP1;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BINDING AFFINITY; DNA SEQUENCE; EXON; GENE ACTIVITY; GENE STRUCTURE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; REPORTER GENE; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION;

ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD44; ANTIGENS, CD95; CELL ADHESION MOLECULES; DNA; EXONS; GUANOSINE; HELA CELLS; HUMANS; JURKAT CELLS; NUCLEIC ACID CONFORMATION; OLIGODEOXYRIBONUCLEOTIDES; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MYC; REGULATORY SEQUENCES, NUCLEIC ACID; SP1 TRANSCRIPTION FACTOR; THIONUCLEOTIDES; TRANSCRIPTION, GENETIC;

EID: 0032824428     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Linsley, P. S., and J. A. Ledbetter. 1993. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11:191.
2. Harding, F. A., J. G. McArthur, J. A. Gross, D. H. Raulet, and J. P. Allison. 1992. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T cell clones. Nature 356:607.
3. Tan, P., C. Anasetti, J. A. Hansen, J. Melrose, M. Brunvand, J. Bradshaw, S. A. Ledbetter, and P. S. Linsley. 1993. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J. Exp. Med. 177:165.
4. L. Immunity 3:87.
5. Lin, H., S. F. Bolling, P. S. Linsley, R. Q. Wei, D. Gordon, C. B. Thompson, and L. A. Turka. 1993. Long term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA-4Ig plus donor-specific transfusion. J. Exp. Med. 178:1801.
6. Lenschow, D. J., Y. Zeng, J. R. Thistlethwaite, A. Montag, W. Brady, M. G. Gibson, and J. A. Bluestone. 1992. Long term survival of xenogeneic pancreatic islets induced by CTLA-4Ig. Science 257:789.
7. Tam, R. C., U. T. Phan, T. Milovanovic, B. Pai, C. Lim, J. Bard, and L. He. 1997. Oligonucleotide-mediated inhibition of CD28 expression induces human T cell hyporesponsiveness and manifests impaired contact hypersensitivity in mice. J. Immunol. 158:200.
8. Bock. L. C., L. C. Griffin, J. A. Latham, E. H. Vermaas, and J. J. Toole. 1992. Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature 355:564.
9. Aruffo, A., and B. Seed. 1987. Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system. Proc. Natl. Acad. Sci. USA 84:8573.
10. Lee, K. P., C. Taylor, B. Petryniak, L. A. Turka, C. H. June, and C. B. Thompson. 1990. The genomic organization of the CD28 gene. Implications for the regulation of CD28 mRNA expression and heterogeneity. J. Immunol. 145:344.
11. Wang, G., P. J. Middleton, L. He, V. Stoisavljevic, and W. E. Seifert. 1997. Synthesis and evaluation of oligodeoxynucleotides containing 3′-C-aminoethyl-and 3′-aminomethythymidine. Nucleosides Nucleotides 16:445.
12. Seed, B., and J. Y. Sheen. 1988. A simple phase-extraction assay for chloramphenicol acetyltransferase activity. Gene 67:271.
13. Skerka, C., E. L. Decker, and P. F. Zipfel. 1995. A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and EGR-1. J. Biol. Chem. 270:22500.
14. Tam, R. C., S. Wu-Pong, B. Pai, C. Lim, A. Chan, D. F. Thomas, T. Milovanovic, J. Bard, and P. Middleton. 1999. Increased potency of an aptameric G-rich oligonucleotide is associated with novel functional properties of phosphorothioate linkages. Antisense Nucleic Acid Drug Dev. 9:289.
15. Kramer, B., A. Meichle, G. Hensel, P. Charnay, and M. Kronke. 1994. Characterization of an Krox-24/EGR-1-responsive element in the human tumor necrosis factor promoter. Biochim. Biophys. Acta 1219:413.
16. Minc, E., P. deCoppet, P. Masson, L. Thiery, S. Dutertre, M. Amor-Gueret, and C. Jaulin. 1999. The human copper-zinc superoxide dismutase gene (SOD1) proximal promoter is regulated by Sp1, EGR-1, and WT1 via non-canonical binding sites. J. Biol. Chem. 274:503.
17. Lin, J. X., and W. J. Leonard. 1997. The immediate-early gene product EGR-1 regulates the human interleukin-2 receptor β-chain promoter through non-canonical Egr and Sp1 binding sites. Mol. Cell. Biol. 17:3714.
18. Khachigian, L. M., K. R. Andersen, N. J. Halnon, M. A. Gimbrone, N. Resnick, and T. Collins. 1997. EGR-1 is activated in endothelial cells exposed to fluid shear stress and interacts with a novel shear-stress-response element in the PDGF A-chain. Arterioscler. Thromb. Vasc. Biol. 17:2280.
19. Rafty, L. A., and L. M. Khachigian. 1998. Zinc finger transcription factor mediate high constitutive platelet-derived growth factor-B expression in smooth muscle cells derived from aortae of newborn rats. J. Biol. Chem. 273:5758.
20. Riva, A., G. L. Wilson, and J. H. Kehrl. 1997. In vivo footprinting and mutational analysis of the proximal CD19 promoter reveal important roles for an Sp1/EGR-1 binding and a novel site termed the PyG box. J. Immunol. 159:1284.
21. Cowan, P. J., D. Tsang, C. M. Pedic, L. R. Abbott, T. A. Shinkel, A. J. d'Apice, and M. J. Pearse. 1998. The human [CAM-2 promoter is endothelial cell-specific in vitro and contains Sp1 and GATA binding sites. J. Biol. Chem. 273:11737.
22. Majello, B., P. De Luca, G. Suske, and L. Lania. 1995. Differential transcription regulation of c-myc promoter through the same DNA binding sites targeted by Sp1-like proteins. Oncogene 10:1841.
23. Maltzman, J. S., J. A. Carmen, and J. G. Monroe. 1996. Transcriptional regulation of the Icam-1 gene in antigen receptor-and phorbol ester-stimulated B lymphocytes: role for transcription factor EGR1. J. Exp. Med. 183:1747.
24. Maltzman, J. S., J. A. Carmen, and J. G. Monroe. 1996. The role of EGR1 in regulation of stimulus-dependent CD44 transcription in B lymphocytes. Mol. Cell. Biol. 16:2283.
25. Dinkel, A., W. K. Aicher, C. Haas, P. F. Zipfel, H.-H. Peter, and H. Eibel. 1997. Transcription factor EGR-1 activity down-regulates Fas and CD23 expression in B cells. J. Immunol. 159:2678.
26. Kim, Y. H., M. A. Buchholz, F. J. Chrest, and A. A. Nordin. 1994. Upregulation of c-myc induces the gene expression of the murine homologues of p34cdc2 and cyclin-dependent kinase-2 in T lymphocytes. J. Immunol. 52:4328.
27. Yaswen, P., M. R. Stampfer, K. Ghosh, and J. S. Cohen. 1993. Effects of sequence of thioated oligonucleotides on cultured human mammary epithelial cells. Antisense Res. Dev. 3:67.
28. Perez, J. R., Y. Li, C. A. Stein, S. Majumder, A. van Oorschot, and R. Narayanan. 1994. Sequence-independent induction of Sp1 transcription factor activity by phosphorothioate oligodeoxy-nucleotides. Proc. Natl. Acad. Sci. USA 91:5957.
29. Maltese, J.-Y., H. W. Sharma, L. Vassilev, and R. Narayanan. 1995. Sequence context of antisense RelA/NFκB phosphoro-thioates determines specificity. Nucleic Acids Res. 23:1146.
30. 2 enzyme activity by phosphorothioate oligonucleotides. Nucleic Acids Res. 22:3202.
31. Higgins, K., J. Perez, T. Coleman, K. Dorshkind, W. McNomas, U. Sarmiento, C. Rosen, and R. Narayanan. 1993. Antisense inhibition of the p65 subunit of NKκB blocks tumorigenicity and causes tumor regression. Proc. Natl, Acad. Sci. USA 90:9901.
32. Blackburn, E. H. 1990. Telomeres: Structure and synthesis. J. Biol. Chem. 265: 5919.
33. Shimizu, A., and T. Honjo. 1984. Immunoglobulin class switching. Cell 36:801.
34. Morishita, R., G. H. Gibbons, M. Horiuchi, Y. Kaneda, T. Ogihara, and V. J. Dzau. 1998. Role of AP-1 complex in angiotensin II-mediated transforming growth faclor-β expression and growth of smooth muscle cells: using decoy approach against AP-1 binding site. Biochem. Biophys. Res. Commun. 243:361.
35. Tomita, N., M. Horiuchi, Tomita, S., G. H. Gibbons, J. Y. Kim, D. Baran, and V. J. Dzau. 1998. An oligonucleotide decoy for transcription factor E2F inhibits mesangial cell proliferation in vitro. Am. J. Physiol. 275:F278.
36. Cho-Chung, Y. S. 1998. CRE-palindrome oligonucleotide as a transcription factor decoy and an inhibitor of tumor growth. Antisense Nucleic Acid Drug Dev. 8:167.
37. Morishita, R., G. H. Gibbons, M. Horiuchi, K. E. Ellison, M. Nakajima, L. Zhang, Y. Kaneda, T. Ogihara, and V. J. Dzau. 1995. A gene therapy strategy using a transcription factor decoy of the E2F-binding site inhibits smooth muscle proliferation in vivo. Proc. Natl. Acad. Sci. USA 92:5855.
38. Maeshima, Y., N. Kashihara, T. Yasuda, H. Sugiyama, T. Sekikawa, K. Okamoto, K. Kanao, Y. Watnabe, Y. S. Kanwar, and H. Makino. 1998. Inhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in vitro and in vivo. J. Clin. Invest. 101:2589.